JPH08502068A - イノシトール１，４，５‐トリスホスフェートを拮抗する方法 - Google Patents

イノシトール１，４，５‐トリスホスフェートを拮抗する方法

Info

Publication number
JPH08502068A
JPH08502068A JP6509054A JP50905494A JPH08502068A JP H08502068 A JPH08502068 A JP H08502068A JP 6509054 A JP6509054 A JP 6509054A JP 50905494 A JP50905494 A JP 50905494A JP H08502068 A JPH08502068 A JP H08502068A
Authority
JP
Japan
Prior art keywords
inositol
triphosphate
binding
calcium
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6509054A
Other languages
English (en)
Japanese (ja)
Inventor
エイ． ストーダーマン，ケネス
Original Assignee
メレルダウファーマスーティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メレルダウファーマスーティカルズ インコーポレイテッド filed Critical メレルダウファーマスーティカルズ インコーポレイテッド
Publication of JPH08502068A publication Critical patent/JPH08502068A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP6509054A 1992-09-28 1993-08-30 イノシトール１，４，５‐トリスホスフェートを拮抗する方法 Pending JPH08502068A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95239392A 1992-09-28 1992-09-28
US07/952,393 1992-09-28
PCT/US1993/008168 WO1994007507A1 (en) 1992-09-28 1993-08-30 Method for antagonizing inositol 1,4,5-triphosphate

Publications (1)

Publication Number Publication Date
JPH08502068A true JPH08502068A (ja) 1996-03-05

Family

ID=25492868

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6509054A Pending JPH08502068A (ja) 1992-09-28 1993-08-30 イノシトール１，４，５‐トリスホスフェートを拮抗する方法

Country Status (13)

Country Link
EP (1) EP0661982A1 (en:Method)
JP (1) JPH08502068A (en:Method)
KR (1) KR950703347A (en:Method)
AU (1) AU670962B2 (en:Method)
CA (1) CA2145681A1 (en:Method)
HU (1) HUT70192A (en:Method)
IL (1) IL107066A (en:Method)
MX (1) MX9305933A (en:Method)
NO (1) NO951163L (en:Method)
NZ (1) NZ256178A (en:Method)
TW (1) TW260663B (en:Method)
WO (1) WO1994007507A1 (en:Method)
ZA (1) ZA936978B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000586A2 (en) * 1994-06-30 1996-01-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Methods for treating cell proliferative disorders by modulating signal transduction
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
EP0809492A4 (en) 1995-02-17 2007-01-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
US6083920A (en) * 1995-12-21 2000-07-04 Ayurcore, Inc. Compositions for modulating intracellular inositol trisphosphate concentration
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
IL127666A0 (en) * 1996-06-27 1999-10-28 Smithkline Beecham Corp IL-8 receptor antagonists
IL127667A0 (en) 1996-06-27 1999-10-28 Smithkline Beecham Corp IL-8 receptor antagonists
WO2002038140A2 (en) * 2000-11-09 2002-05-16 Contrimmune Biotechnology Inc Therapeutic uses for ip3 receptor-mediated calcium channel modulators
EP3072555B1 (en) 2011-09-02 2020-03-25 The Trustees of Columbia University in the City of New York Mk2/3 inhibitors to treat metabolic disturbances of obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
NO951163D0 (no) 1995-03-27
NO951163L (no) 1995-03-27
HU9500891D0 (en) 1995-05-29
ZA936978B (en) 1994-04-18
IL107066A (en) 1998-01-04
NZ256178A (en) 1997-03-24
IL107066A0 (en) 1993-12-28
EP0661982A1 (en) 1995-07-12
CA2145681A1 (en) 1994-04-14
KR950703347A (ko) 1995-09-20
MX9305933A (es) 1994-04-29
AU4841793A (en) 1994-04-26
AU670962B2 (en) 1996-08-08
WO1994007507A1 (en) 1994-04-14
TW260663B (en:Method) 1995-10-21
HUT70192A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
DE69331888T2 (de) Bicyclische Pyridinderivate, Verfahren zu ihrer Herstellung, Zwischenprodukte, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen
US20040006120A1 (en) Use of histamine h3 receptor inverse agonists for the control of appetite and treatment of obesity
JP3000674B2 (ja) ジヒドロピラゾロピロール類
RU2378274C2 (ru) ПИРАЗОЛО[3,4-b]ПИРИДИНОВОЕ СОЕДИНЕНИЕ И ЕГО ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРА ФДЭ4
US5204329A (en) Treatment of organ transplantation rejection
DE68913831T2 (de) Kondensierte Pyrimidinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
Laduron et al. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
DE69920476T2 (de) Liganden mit hoher affinität für den nociceptin-rezeptor orl-1
US6448253B1 (en) Adenosine A3 receptor modulators
DE69726724T2 (de) Tetrahydropteridine und pyridylpiperazine zur behandlung von neurologischen störungen
US20170266192A1 (en) Methods for improving diaphragm function
JP2003119155A (ja) 女性の性機能障害の治療及び女性の性機能障害の治療に有用な化合物の同定方法
EP0683781B1 (en) Novel inhibitors of adenosine monophosphate deaminase
JP2001508798A (ja) ケモカインレセプター活性のモジュレーターとしての３，３−二置換ピペリジン類
JP2002526443A (ja) 緑内障治療用セロトニン作動性５ｈｔ２作用物質
JP2001302547A (ja) 女性の性機能不全を処置するための組成物および方法
JPH08502068A (ja) イノシトール１，４，５‐トリスホスフェートを拮抗する方法
IE872051L (en) Use of serotonin antagonists
BRPI0414663A (pt) derivados triazol substituìdos como antagonistas de oxitocina
JPS60502204A (ja) 新規なアミジン類、その製法と治療応用
DE69624829T2 (de) Thienopyrimidinderivate als endothelin antagonisten
Coupet et al. Brain histamine H1-and H2-receptors and histamine-sensitive adenylate cyclase: effects of antipsychotics and antidepressants
KR840000077B1 (ko) 10,11-디하이드로-5H-디벤조[a, d]사이클로 헵텐-5, 10-이민의 제조방법.
EP0067508A1 (en) Amidine derivatives
Lee et al. Potent enhancement of [3H] nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330 A.